This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Shannon J. Turley, Ph.D.
Vice President, Cancer Immunology Discovery at Genentech


Dr. Turley is the Vice President of Cancer Immunology Discovery, Senior Fellow and Cancer Immunology Therapeutic Area Head at Genentech. where she oversees the Cancer Immunotherapy portfolio including early stage research to early clinical development. Prior to joining Genentech in 2014, Dr. Turley served on the faculty at Dana Farber Cancer Institute (DFCI) and Harvard Medical School (HMS) as well as the Associate Director of the Harvard PhD Program in Immunology. Dr. Turley has extensive experience in research and drug development focused on stromal, immune and tissue biology in cancer, fibrosis, inflammation and autoimmune diseases. Dr. Turley received her PhD from Yale University School of Medicine and postdoctoral training at Joslin Diabetes Center at Harvard Medical School.

Agenda Sessions

  • Stromal Cell Evolution, Clinical Relevance and Therapeutic Targeting in Oncology and Fibrosis